Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...

A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same leukemia-causing gene mutation can have dramatically different outcomes: it depends on ...

From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a ...

This radical new method could preserve our entire knowledge base for thousands of years, in a storage medium the size of a coffee cup.

This week, Svante Pääbo, Nobel Prize winner for sequencing the Neanderthal genome, is visiting Estonia. In an interview with ...

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common illnesses. So far, only 15 people have received the treatment. But, if all ...

A new paper from the University of Kansas overturns the idea that a "risk gene" carried by millions of people worldwide influences production of Type 1 interferon, a workhorse of the immune system.

PhD Defense: From genes to enhancers and everything in between The role of enhancer distance in transcriptional regulation Anna-Karina Felder From genes to enhancers and everything in between: The ...

Kennesaw State University senior biology major Ari Schwartz has been recognized with the President’s Award of Distinction and ...

This article examines some of the cell-based approaches that researchers are using to study acquired drug resistance and the effects of specific genetic variants on cancer cell physiology.

Hosts David and Gina explore how scientists over the centuries unlocked the ability to edit our genes ...

Researchers are expanding the scope of cell and gene therapies to target chronic diseases that are difficult to treat.